Tag: liver cancer
-
Liver Cancer Early Detection Gets a Boost from ALTUS Blood Test Study
Groundbreaking ALTUS Study Highlights Blood-Based Liver Cancer Detection Exact Sciences Corp. today announced pivotal validation results from the ALTUS study (NCT: 05064553), a prospective, head-to-head evaluation of a blood-based surveillance test for liver cancer detection. The findings, presented by the company in Madison, Wisconsin, suggest clear improvements in identifying liver cancer at an earlier, more…
-
Exact Sciences Unveils Breakthrough Blood Test for Early Liver Cancer Detection
Groundbreaking Validation of a Blood-Based Liver Cancer Screening Tool Exact Sciences Corp. has announced pivotal clinical validation results from the ALTUS study, a prospective, head-to-head evaluation designed to assess a blood-based surveillance test for liver cancer. Conducted in a real-world, high-risk population, the ALTUS study (NCT: 05064553) represents a major step toward accessible, non-invasive screening…
-
Exact Sciences Unveils Breakthrough: Blood-Based Test Boosts Early Liver Cancer Detection
Breakthrough in Liver Cancer Detection Exact Sciences Corp. announced pivotal clinical validation results from the ALTUS study, signaling a major step forward in the early detection of liver cancer through a blood-based surveillance test. The prospective, head-to-head study (NCT: 05064553) evaluated the test’s performance against existing screening modalities, with results indicating superior sensitivity and specificity…
-
Free Nurse-Led Support Line for Primary Liver Cancer Now Open
A new lifeline for liver cancer patients October is Liver Cancer Awareness Month, and the Liver Foundation has launched a free, nurse-led support line dedicated to primary liver cancer. The service provides no-cost access to expert guidance and compassionate care, offering patients and their loved ones a trusted space to seek information, reassurance, and practical…
-
Free, Nurse-Led Support Line Opens for Primary Liver Cancer During Liver Cancer Awareness Month
A New Lifeline for Primary Liver Cancer Patients In a significant move to bolster support for those affected by primary liver cancer, the Liver Foundation has launched a free, nurse-led support line during Liver Cancer Awareness Month. The service is designed to provide expert guidance, compassionate listening, and practical information to patients and their loved…
-
Liver Cancer Support Line: Free Nurse-Led Help for Patients
A Free, Nurse-Led Support Line for Primary Liver Cancer October is Liver Cancer Awareness Month, a time to spotlight a rising health concern and the resources available to those affected. The Liver Foundation has announced a new, free support line led by experienced nurses who specialize in primary liver cancer and the broader spectrum of…
-
Hospitalization Spending on Cancers in Hunan, China (2017–2019): A Comprehensive Look at Costs and Determinants
Overview Cacing the economic burden of cancer requires looking beyond incidence and mortality to how hospitalization costs accumulate. A retrospective study using the CNHSNRS data from 2017–2019 in Hunan Province, China, quantified inpatient spending for all cancers, described the cost distribution across cancer sites and patient characteristics, and identified factors associated with higher per-admission costs.…
-
CORE Model: Simple Blood Tests Predict Liver Disease Risk
What is the CORE model? A new tool, the CORE model, is being developed to help primary care teams assess the risk of serious liver diseases. The aim is to identify patients who are at higher risk of conditions such as cirrhosis, liver cancer, or the potential need for a liver transplant within the next…
-
Simple Test Predicts Liver Disease: CORE Model Uses Three Blood Tests
What is the CORE model? A new risk-prediction tool called CORE has been developed to help primary care. It uses information from three simple blood tests that are already collected in routine checkups to estimate a patient’s ten-year risk of developing serious liver problems, including cirrhosis, liver cancer, or the need for a liver transplant.…
-
CORE Model Uses Three Blood Tests to Predict Liver Disease Risk
What is the CORE model and why it matters Liver disease is on the rise, and outcomes worsen when it is detected late. A new tool, known as the CORE model, has been developed to help primary care clinicians assess a patient’s risk of severe liver conditions before symptoms appear. By relying on three simple…